Nothing Special   »   [go: up one dir, main page]

Roman et al., 1996 - Google Patents

Expanded CD4^+ CD45RO^+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease

Roman et al., 1996

View PDF
Document ID
9093761969226084991
Author
Roman L
Manzano L
De la Hera A
Abreu L
Rossi I
Alvarez-Mon M
Publication year
Publication venue
GASTROENTEROLOGY-BALTIMORE THEN PHILADELPHIA-

External Links

Snippet

Background & Aims: An abnormal immune response toplasmatic enzymatic systems, and cytokines (mono-may play a pathogenic role in Crohn's disease. The aim kines and lymphokines). T-lymphocyte activation begins of this study was to determine the role of …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Roman et al. Expanded CD4^+ CD45RO^+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease
Wu et al. Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis
Alvarado-Sánchez et al. Regulatory T cells in patients with systemic lupus erythematosus
Brune et al. Downregulation of T helper type 1 immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery
Van den Hove et al. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma
Yamashita et al. Role of γδ T lymphocytes in the development of Behc¸ et's disease
Bhagat et al. Small intestinal CD8+ TCRγδ+ NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease
Leprince et al. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.
Ginsburg et al. Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus
Pallone et al. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.
Ernst et al. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules.
Thomas et al. Identification of lymphocyte subsets in the newborn using a variety of monoclonal antibodies.
Cossarizza et al. Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome
EP0025722A2 (en) Monoclonal antibody to human cytotoxic and suppressor T cells, and method of preparing it
Bhardwaj et al. Interleukin-1 production by mononuclear cells from rheumatoid synovial effusions
Sheu et al. Down-regulation of CD25 expression on the surface of activated tumor-infiltrating lymphocytes in human cervical carcinoma
Mizutani et al. T‐cell abnormalities in patients with idiopathic thrombocytopenic purpura: The presence of OKT4+ 8+ cells
Le Moal et al. Urtica dioica agglutinin, a new mitogen for murine T lymphocytes: unaltered interleukin-1 production but late interleukin 2-mediated proliferation
Clerici et al. Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infection
Sieber et al. Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease.
Giacomelli et al. Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients
Pignata et al. Impaired suppressor activity in children affected by coeliac disease.
Dakhama et al. Role of interleukin-2 in the development and persistence of lymphocytic alveolitis in farmer's lung
Socha et al. Deficiency of the expression of CD45RA isoform of CD45 common leukocyte antigen in CD4+ T lymphocytes in children with infantile cholestasis
Domingo et al. Human pregnancy serum inhibits proliferation of T8-depleted cells and their interleukin-2 synthesis in mixed lymphocyte cultures